Markets:

Overview

News

Currencies

International

Treasuries

Cybin Inc. Common Shares (NY:CYBN)

6.170 +0.280 (+4.75%)

Official Closing Price Updated: 8:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cybin Inc. Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors ↗

May 24, 2025

Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.

Via Benzinga

Topics Government

Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks. ↗

April 10, 2025

From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care.

Via Investor's Business Daily

Topics Government

MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday ↗

February 13, 2025

Via Benzinga

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care. ↗

February 12, 2025

The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.

Via Investor's Business Daily

CYBN Stock Earnings: Cybin Beats EPS for Q1 2024 ↗

August 09, 2024

CYBN stock results show that Cybin beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

CYBN Stock Earnings: Cybin Beats EPS for Q4 2023 ↗

June 26, 2024

CYBN stock results show that Cybin beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

What's Next: Cybin's Earnings Preview ↗

November 12, 2025

Via Benzinga

What's going on in today's pre-market session ↗

October 28, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

3 High-Risk, High-Reward Stocks With Explosive Upside ↗

July 16, 2025

Rezolve, Aurora, and Cybin are 2025's top growth stocks in AI, driverless trucks, and psychedelics, with huge upside potential and key catalysts unfolding.

Via MarketBeat

Topics Artificial Intelligence

Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming ↗

June 03, 2025

Federal support for psychedelics is rising fast. One biotech CEO explains what it means for clinical trials, access, and real-world therapy.

Via Benzinga

RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box. ↗

February 04, 2025

RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines in favor of his nomination.

Via Investor's Business Daily

Is Your Mind Ready to Consider Investing in Psychedelics Stocks? ↗

November 29, 2024

Don't jump in without doing some research first.

Via The Motley Fool

Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression ↗

November 13, 2024

Cybin starts Phase 3 trials for its depression treatment, CYB003, backed by strong Phase 2 data and a solid cash position.

Via Benzinga

EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program ↗

October 24, 2024

Cybin secures a U.S. patent for its CYB005 program targeting CNS disorders and prepares to launch a Phase 3 trial for CYB003 in major depressive disorder.

Via Benzinga

Topics Intellectual Property

Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More ↗

September 06, 2024

Maryland transitioned to an adult-use cannabis market a little over a year ago. Led by the state's Cannabis Administration Director, Will Tilburg, the transition resulted in the state's legal cannabis...

Via Benzinga

Topics Cannabis

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves ↗

July 31, 2024

Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.

Via Benzinga

3 Biotech Stocks That Could Make Your Summer Unforgettable ↗

July 30, 2024

If you want to do well with biotech stocks, trade the anticipation of news. Here are three stocks to consider.

Via InvestorPlace

Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns ↗

July 03, 2024

Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks.

Via InvestorPlace

3 Psychedelic Stocks to Buy on the Dip: Summer 2024 ↗

July 02, 2024

These are three of the best psychedelic stocks to buy on the dip for potentially lucrative future growth and returns.

Via InvestorPlace

Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development ↗

June 26, 2024

Explore Cybin Inc.'s FY 2024 results: $78M loss and strides in psychedelic therapy for mental health. Read now!

Via Benzinga

Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More ↗

June 18, 2024

As the premier gathering of top entrepreneurs and investors is taking place this Monday in New Jersey, let's scroll through the latest leadership changes in the cannabis and psychedelics...

Via Benzinga

Topics Cannabis

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment ↗

June 05, 2024

FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.

Via Benzinga

Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon ↗

May 09, 2024

Via Benzinga

Topics Cannabis

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More ↗

March 30, 2024

Via Benzinga

3 Penny Stocks That Could Be Multibaggers in the Making: March Edition ↗

March 26, 2024

Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while.

Via InvestorPlace

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More ↗

March 20, 2024

Via Benzinga

Topics Economy

FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement ↗

March 13, 2024

Via Benzinga

3 High-Potential Penny Stocks to Turn $1000 into $1 million ↗

March 10, 2024

U.S. equities are in the midst of a steady rally, but these high-potential penny stocks are likely to trounce the major indices.

Via InvestorPlace

Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More ↗

March 04, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cybin Inc. Common Shares (NY:CYBN)

Headline News about Cybin Inc. Common Shares

Starting at $3.75/week.

Subscribe Today